A detailed history of Pds Planning, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Pds Planning, Inc holds 14,842 shares of JNJ stock, worth $2.13 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
14,842
Previous 14,113 5.17%
Holding current value
$2.13 Million
Previous $2.06 Million 16.63%
% of portfolio
0.22%
Previous 0.21%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$145.48 - $167.38 $106,054 - $122,020
729 Added 5.17%
14,842 $2.41 Million
Q2 2024

Aug 07, 2024

SELL
$144.38 - $157.78 $145,246 - $158,726
-1,006 Reduced 6.65%
14,113 $2.06 Million
Q1 2024

May 01, 2024

BUY
$155.22 - $162.74 $54,792 - $57,447
353 Added 2.39%
15,119 $2.39 Million
Q4 2023

Feb 01, 2024

SELL
$145.6 - $158.88 $4,368 - $4,766
-30 Reduced 0.2%
14,766 $2.31 Million
Q3 2023

Oct 20, 2023

SELL
$155.75 - $174.48 $101,860 - $114,109
-654 Reduced 4.23%
14,796 $2.3 Million
Q2 2023

Jul 20, 2023

BUY
$154.35 - $166.11 $160,060 - $172,256
1,037 Added 7.19%
15,450 $2.56 Million
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $608,731 - $726,447
4,030 Added 38.81%
14,413 $2.23 Million
Q4 2022

Jan 26, 2023

BUY
$160.2 - $179.79 $4,966 - $5,573
31 Added 0.3%
10,383 $0
Q3 2022

Nov 02, 2022

BUY
$161.33 - $179.52 $83,084 - $92,452
515 Added 5.24%
10,352 $1.69 Million
Q2 2022

Jul 15, 2022

BUY
$168.19 - $186.01 $128,160 - $141,739
762 Added 8.4%
9,837 $1.75 Million
Q1 2022

Apr 18, 2022

BUY
$158.14 - $179.59 $101,842 - $115,655
644 Added 7.64%
9,075 $1.61 Million
Q4 2021

Jan 25, 2022

SELL
$155.93 - $173.01 $44,440 - $49,307
-285 Reduced 3.27%
8,431 $1.44 Million
Q3 2021

Oct 22, 2021

BUY
$161.5 - $179.47 $52,326 - $58,148
324 Added 3.86%
8,716 $1.41 Million
Q2 2021

Jul 26, 2021

BUY
$159.48 - $171.07 $117,855 - $126,420
739 Added 9.66%
8,392 $1.38 Million
Q1 2021

Apr 20, 2021

BUY
$153.07 - $170.48 $44,849 - $49,950
293 Added 3.98%
7,653 $1.26 Million
Q4 2020

Jan 21, 2021

BUY
$137.11 - $157.38 $20,292 - $23,292
148 Added 2.05%
7,360 $1.16 Million
Q3 2020

Oct 19, 2020

BUY
$140.38 - $153.83 $61,907 - $67,839
441 Added 6.51%
7,212 $1.07 Million
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $118,118 - $142,602
917 Added 15.66%
6,771 $952,000
Q1 2020

Apr 20, 2020

BUY
$111.14 - $153.99 $67,350 - $93,317
606 Added 11.55%
5,854 $768,000
Q4 2019

Feb 07, 2020

BUY
$127.5 - $146.44 $1,020 - $1,171
8 Added 0.15%
5,248 $766,000
Q3 2019

Oct 28, 2019

BUY
$126.95 - $142.14 $47,479 - $53,160
374 Added 7.69%
5,240 $678,000
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $58,886 - $64,763
449 Added 10.17%
4,866 $678,000
Q1 2019

Apr 19, 2019

BUY
$125.72 - $139.79 $43,499 - $48,367
346 Added 8.5%
4,417 $617,000
Q4 2018

Feb 08, 2019

BUY
$122.84 - $147.84 $48,890 - $58,840
398 Added 10.84%
4,071 $525,000
Q3 2018

Nov 02, 2018

BUY
$121.58 - $142.88 $43,404 - $51,008
357 Added 10.77%
3,673 $507,000
Q2 2018

Jul 27, 2018

SELL
$119.4 - $131.76 $7,641 - $8,432
-64 Reduced 1.89%
3,316 $402,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $443,523 - $485,435
3,380
3,380 $472,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $375B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pds Planning, Inc Portfolio

Follow Pds Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.